| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytidine deaminase activity | 1.60e-09 | 13 | 26 | 4 | GO:0004126 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 2.81e-08 | 146 | 26 | 6 | GO:0016810 | |
| GeneOntologyMolecularFunction | deaminase activity | 1.02e-07 | 34 | 26 | 4 | GO:0019239 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 1.29e-07 | 36 | 26 | 4 | GO:0016814 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 9.77e-06 | 4 | 26 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 9.77e-06 | 4 | 26 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | sodium channel inhibitor activity | 4.54e-05 | 8 | 26 | 2 | GO:0019871 | |
| GeneOntologyMolecularFunction | trace-amine receptor activity | 4.54e-05 | 8 | 26 | 2 | GO:0001594 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.69e-04 | 15 | 26 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | deacetylase activity | 1.23e-03 | 40 | 26 | 2 | GO:0019213 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.30e-03 | 41 | 26 | 2 | GO:0008227 | |
| GeneOntologyMolecularFunction | sodium channel regulator activity | 1.49e-03 | 44 | 26 | 2 | GO:0017080 | |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 1.70e-03 | 47 | 26 | 2 | GO:0016790 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 1.77e-03 | 48 | 26 | 2 | GO:0008200 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 1.92e-03 | 50 | 26 | 2 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 2.00e-03 | 51 | 26 | 2 | GO:0141110 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.32e-03 | 55 | 26 | 2 | GO:0008146 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 3.62e-03 | 1189 | 26 | 6 | GO:0046914 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 4.16e-03 | 74 | 26 | 2 | GO:0016782 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 4.96e-03 | 81 | 26 | 2 | GO:0016811 | |
| GeneOntologyMolecularFunction | zinc ion binding | 5.26e-03 | 891 | 26 | 5 | GO:0008270 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 2.97e-11 | 6 | 26 | 4 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 2.97e-11 | 6 | 26 | 4 | GO:0099046 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 4.14e-10 | 10 | 26 | 4 | GO:0070383 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 9.75e-10 | 12 | 26 | 4 | GO:0016554 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 1.97e-09 | 14 | 26 | 4 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 1.97e-09 | 14 | 26 | 4 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 1.97e-09 | 14 | 26 | 4 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 1.97e-09 | 14 | 26 | 4 | GO:0045006 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 3.57e-09 | 16 | 26 | 4 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 3.57e-09 | 16 | 26 | 4 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 3.57e-09 | 16 | 26 | 4 | GO:0046133 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 6.00e-09 | 18 | 26 | 4 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 7.59e-09 | 19 | 26 | 4 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 7.59e-09 | 19 | 26 | 4 | GO:0016553 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 9.48e-09 | 20 | 26 | 4 | GO:0039692 | |
| GeneOntologyBiologicalProcess | ribonucleoside catabolic process | 2.91e-08 | 26 | 26 | 4 | GO:0042454 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside metabolic process | 3.41e-08 | 27 | 26 | 4 | GO:0006213 | |
| GeneOntologyBiologicalProcess | DNA modification | 6.10e-08 | 31 | 26 | 4 | GO:0006304 | |
| GeneOntologyBiologicalProcess | viral RNA genome replication | 6.96e-08 | 32 | 26 | 4 | GO:0039694 | |
| GeneOntologyBiologicalProcess | nucleoside catabolic process | 6.96e-08 | 32 | 26 | 4 | GO:0009164 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule catabolic process | 1.27e-07 | 37 | 26 | 4 | GO:0034656 | |
| GeneOntologyBiologicalProcess | glycosyl compound catabolic process | 1.95e-07 | 41 | 26 | 4 | GO:1901658 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 3.12e-07 | 46 | 26 | 4 | GO:0072529 | |
| GeneOntologyBiologicalProcess | transposable element silencing | 3.12e-07 | 46 | 26 | 4 | GO:0010526 | |
| GeneOntologyBiologicalProcess | ribonucleoside metabolic process | 3.72e-07 | 48 | 26 | 4 | GO:0009119 | |
| GeneOntologyBiologicalProcess | retrotransposition | 3.72e-07 | 48 | 26 | 4 | GO:0032197 | |
| GeneOntologyBiologicalProcess | transposition | 4.39e-07 | 50 | 26 | 4 | GO:0032196 | |
| GeneOntologyBiologicalProcess | negative regulation of viral genome replication | 6.97e-07 | 56 | 26 | 4 | GO:0045071 | |
| GeneOntologyBiologicalProcess | nucleoside metabolic process | 1.53e-06 | 68 | 26 | 4 | GO:0009116 | |
| GeneOntologyBiologicalProcess | regulation of viral genome replication | 4.92e-06 | 91 | 26 | 4 | GO:0045069 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound metabolic process | 5.14e-06 | 92 | 26 | 4 | GO:0072527 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 6.09e-06 | 96 | 26 | 4 | GO:1901657 | |
| GeneOntologyBiologicalProcess | negative regulation of viral process | 8.06e-06 | 103 | 26 | 4 | GO:0048525 | |
| GeneOntologyBiologicalProcess | viral genome replication | 2.49e-05 | 137 | 26 | 4 | GO:0019079 | |
| GeneOntologyBiologicalProcess | regulation of viral life cycle | 4.13e-05 | 156 | 26 | 4 | GO:1903900 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 4.26e-05 | 8 | 26 | 2 | GO:0015014 | |
| GeneOntologyBiologicalProcess | viral life cycle | 5.85e-05 | 340 | 26 | 5 | GO:0019058 | |
| GeneOntologyBiologicalProcess | RNA modification | 6.61e-05 | 176 | 26 | 4 | GO:0009451 | |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at postsynapse | 6.83e-05 | 10 | 26 | 2 | GO:0140252 | |
| GeneOntologyBiologicalProcess | regulation of viral process | 8.19e-05 | 186 | 26 | 4 | GO:0050792 | |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 8.35e-05 | 11 | 26 | 2 | GO:0030210 | |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at synapse | 1.38e-04 | 14 | 26 | 2 | GO:0140250 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression via chromosomal CpG island demethylation | 1.59e-04 | 15 | 26 | 2 | GO:0044029 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 1.60e-04 | 421 | 26 | 5 | GO:0044282 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transmembrane transporter activity | 1.81e-04 | 16 | 26 | 2 | GO:2000650 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.94e-04 | 90 | 26 | 3 | GO:0050688 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transmembrane transport | 2.05e-04 | 17 | 26 | 2 | GO:1902306 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 2.05e-04 | 17 | 26 | 2 | GO:0030202 | |
| GeneOntologyBiologicalProcess | viral process | 2.51e-04 | 464 | 26 | 5 | GO:0016032 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transport | 3.48e-04 | 22 | 26 | 2 | GO:0010766 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | 6.72e-04 | 323 | 26 | 4 | GO:1901136 | |
| GeneOntologyBiologicalProcess | defense response to virus | 8.32e-04 | 342 | 26 | 4 | GO:0051607 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 8.86e-04 | 35 | 26 | 2 | GO:0015012 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor internalization | 1.10e-03 | 39 | 26 | 2 | GO:0099149 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 1.57e-03 | 696 | 26 | 5 | GO:0034655 | |
| GeneOntologyBiologicalProcess | response to virus | 1.85e-03 | 425 | 26 | 4 | GO:0009615 | |
| GeneOntologyBiologicalProcess | postsynaptic endocytosis | 1.88e-03 | 51 | 26 | 2 | GO:0140239 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor internalization | 1.88e-03 | 51 | 26 | 2 | GO:0098884 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 1.90e-03 | 197 | 26 | 3 | GO:0002244 | |
| GeneOntologyBiologicalProcess | protein monoubiquitination | 2.10e-03 | 54 | 26 | 2 | GO:0006513 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.21e-03 | 208 | 26 | 3 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transporter activity | 2.34e-03 | 57 | 26 | 2 | GO:2000649 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 2.42e-03 | 58 | 26 | 2 | GO:0099590 | |
| GeneOntologyBiologicalProcess | protein deacylation | 2.42e-03 | 58 | 26 | 2 | GO:0035601 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 2.85e-03 | 63 | 26 | 2 | GO:0098732 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transporter activity | 2.85e-03 | 63 | 26 | 2 | GO:1901016 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 2.98e-03 | 231 | 26 | 3 | GO:0006352 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 3.03e-03 | 65 | 26 | 2 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 3.31e-03 | 68 | 26 | 2 | GO:0141137 | |
| GeneOntologyBiologicalProcess | regulation of sodium ion transmembrane transport | 3.40e-03 | 69 | 26 | 2 | GO:1902305 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 3.50e-03 | 70 | 26 | 2 | GO:0030166 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | 3.59e-03 | 1226 | 26 | 6 | GO:1901135 | |
| GeneOntologyBiologicalProcess | polysaccharide biosynthetic process | 4.11e-03 | 76 | 26 | 2 | GO:0000271 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 4.11e-03 | 76 | 26 | 2 | GO:0006024 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 4.55e-03 | 80 | 26 | 2 | GO:0006023 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.86e-03 | 275 | 26 | 3 | GO:0006814 | |
| GeneOntologyBiologicalProcess | negative regulation of ion transmembrane transporter activity | 5.35e-03 | 87 | 26 | 2 | GO:0032413 | |
| GeneOntologyCellularComponent | P-body | 1.86e-07 | 102 | 27 | 5 | GO:0000932 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.18e-05 | 269 | 27 | 5 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.97e-05 | 287 | 27 | 5 | GO:0035770 | |
| MousePheno | decreased susceptibility to Ortervirales infection | 3.92e-07 | 12 | 18 | 3 | MP:0020920 | |
| MousePheno | increased susceptibility to Retroviridae infection | 3.92e-07 | 12 | 18 | 3 | MP:0020934 | |
| MousePheno | decreased susceptibility to Retroviridae infection | 3.92e-07 | 12 | 18 | 3 | MP:0020935 | |
| MousePheno | increased susceptibility to Ortervirales infection | 5.09e-07 | 13 | 18 | 3 | MP:0020919 | |
| MousePheno | abnormal susceptibility to Retroviridae infection | 1.71e-06 | 19 | 18 | 3 | MP:0020933 | |
| MousePheno | abnormal susceptibility to Ortervirales infection | 2.02e-06 | 20 | 18 | 3 | MP:0020918 | |
| MousePheno | abnormal immunoglobulin level | 3.76e-04 | 513 | 18 | 5 | MP:0002490 | |
| MousePheno | abnormal tumor morphology | 4.81e-04 | 122 | 18 | 3 | MP:0003448 | |
| MousePheno | decreased susceptibility to viral infection | 5.16e-04 | 125 | 18 | 3 | MP:0002410 | |
| MousePheno | abnormal humoral immune response | 5.81e-04 | 564 | 18 | 5 | MP:0001800 | |
| Domain | APOBEC_N | 1.45e-09 | 12 | 26 | 4 | IPR013158 | |
| Domain | APOBEC_N | 1.45e-09 | 12 | 26 | 4 | PF08210 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 2.92e-09 | 14 | 26 | 4 | IPR016192 | |
| Domain | CMP_dCMP_Zn-bd | 6.93e-09 | 17 | 26 | 4 | IPR002125 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 6.93e-09 | 17 | 26 | 4 | PS00903 | |
| Domain | Cytidine_deaminase-like | 6.93e-09 | 17 | 26 | 4 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_2 | 1.08e-06 | 15 | 26 | 3 | PS51747 | |
| Domain | TAAR1 | 1.86e-06 | 2 | 26 | 2 | IPR009133 | |
| Domain | HSNSD | 1.12e-05 | 4 | 26 | 2 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 1.12e-05 | 4 | 26 | 2 | IPR021930 | |
| Domain | TAAR_fam | 3.90e-05 | 7 | 26 | 2 | IPR009132 | |
| Domain | HECT | 6.40e-04 | 27 | 26 | 2 | PF00632 | |
| Domain | HECTc | 6.40e-04 | 27 | 26 | 2 | SM00119 | |
| Domain | HECT_dom | 6.40e-04 | 27 | 26 | 2 | IPR000569 | |
| Domain | HECT | 6.40e-04 | 27 | 26 | 2 | PS50237 | |
| Domain | Abhydrolase_1 | 8.45e-04 | 31 | 26 | 2 | PF00561 | |
| Domain | AB_hydrolase_1 | 9.58e-04 | 33 | 26 | 2 | IPR000073 | |
| Domain | Sulfotransferase_dom | 1.14e-03 | 36 | 26 | 2 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.14e-03 | 36 | 26 | 2 | PF00685 | |
| Domain | WW | 1.94e-03 | 47 | 26 | 2 | PF00397 | |
| Domain | WW | 2.02e-03 | 48 | 26 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 2.28e-03 | 51 | 26 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 2.28e-03 | 51 | 26 | 2 | PS01159 | |
| Domain | WW_dom | 2.37e-03 | 52 | 26 | 2 | IPR001202 | |
| Domain | 7TM_GPCR_Srsx | 1.05e-02 | 112 | 26 | 2 | SM01381 | |
| Domain | - | 1.18e-02 | 119 | 26 | 2 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 1.18e-02 | 119 | 26 | 2 | IPR029058 | |
| Domain | GPCR_Rhodpsn_7TM | 1.31e-02 | 670 | 26 | 4 | IPR017452 | |
| Domain | 7tm_1 | 1.36e-02 | 677 | 26 | 4 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.41e-02 | 685 | 26 | 4 | PS00237 | |
| Domain | C2 | 1.42e-02 | 131 | 26 | 2 | PF00168 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.45e-02 | 691 | 26 | 4 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.46e-02 | 692 | 26 | 4 | IPR000276 | |
| Domain | C2 | 1.55e-02 | 137 | 26 | 2 | SM00239 | |
| Domain | C2 | 1.66e-02 | 142 | 26 | 2 | PS50004 | |
| Domain | - | 1.79e-02 | 148 | 26 | 2 | 2.60.40.150 | |
| Domain | C2_dom | 2.17e-02 | 164 | 26 | 2 | IPR000008 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 9.93e-08 | 7 | 21 | 3 | MM15412 | |
| Pathway | REACTOME_MRNA_EDITING | 2.38e-07 | 9 | 21 | 3 | MM15445 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 5.89e-05 | 8 | 21 | 2 | M27683 | |
| Pathway | REACTOME_MRNA_EDITING | 9.44e-05 | 10 | 21 | 2 | M27709 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 1.15e-04 | 11 | 21 | 2 | M47921 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 6.72e-04 | 26 | 21 | 2 | M7330 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 8.38e-04 | 29 | 21 | 2 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 9.58e-04 | 31 | 21 | 2 | M685 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 1.67e-03 | 41 | 21 | 2 | M48095 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.76e-03 | 42 | 21 | 2 | MM14971 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.76e-03 | 42 | 21 | 2 | M5868 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 2.89e-03 | 54 | 21 | 2 | MM14633 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 3.21e-03 | 57 | 21 | 2 | M692 | |
| Pubmed | Species-specific restriction of apobec3-mediated hypermutation. | 2.88e-13 | 4 | 27 | 4 | 18032489 | |
| Pubmed | 2.88e-13 | 4 | 27 | 4 | 18702815 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 18577210 | ||
| Pubmed | 1.44e-12 | 5 | 27 | 4 | 18304004 | ||
| Pubmed | Retroelements versus APOBEC3 family members: No great escape from the magnificent seven. | 4.31e-12 | 6 | 27 | 4 | 22912627 | |
| Pubmed | An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. | 1.01e-11 | 7 | 27 | 4 | 11863358 | |
| Pubmed | APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. | 1.01e-11 | 7 | 27 | 4 | 16527742 | |
| Pubmed | 1.01e-11 | 7 | 27 | 4 | 21835787 | ||
| Pubmed | APOBEC3 proteins mediate the clearance of foreign DNA from human cells. | 1.01e-11 | 7 | 27 | 4 | 20062055 | |
| Pubmed | 2.01e-11 | 8 | 27 | 4 | 24227842 | ||
| Pubmed | 6.03e-11 | 10 | 27 | 4 | 23043103 | ||
| Pubmed | Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS. | 6.03e-11 | 10 | 27 | 4 | 20174454 | |
| Pubmed | 9.47e-11 | 11 | 27 | 4 | 12683974 | ||
| Pubmed | HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. | 9.47e-11 | 11 | 27 | 4 | 22915799 | |
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 4.17e-10 | 3 | 27 | 3 | 32641479 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 4.17e-10 | 3 | 27 | 3 | 24840555 | |
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 4.17e-10 | 3 | 27 | 3 | 17967065 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 4.17e-10 | 3 | 27 | 3 | 27602762 | |
| Pubmed | The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. | 4.17e-10 | 3 | 27 | 3 | 23001005 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 20335265 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 286744 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 4.17e-10 | 3 | 27 | 3 | 29593034 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 22691411 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 31830125 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 4.17e-10 | 3 | 27 | 3 | 22666481 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 9765497 | ||
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 4.17e-10 | 3 | 27 | 3 | 24577894 | |
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 4.17e-10 | 3 | 27 | 3 | 21998583 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 24453360 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 24725948 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 4.17e-10 | 3 | 27 | 3 | 16648136 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 4.17e-10 | 3 | 27 | 3 | 38115583 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 4.17e-10 | 3 | 27 | 3 | 23533681 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 20702647 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 1541833 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 27356895 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 23449789 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 23315078 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 20980520 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 4.17e-10 | 3 | 27 | 3 | 25589647 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 284359 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 2157836 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 20617165 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 4.17e-10 | 3 | 27 | 3 | 35458563 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 31801862 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 22275865 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 4.17e-10 | 3 | 27 | 3 | 18434399 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 20943965 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 4.17e-10 | 3 | 27 | 3 | 39208378 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 31943071 | ||
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 4.17e-10 | 3 | 27 | 3 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 4.17e-10 | 3 | 27 | 3 | 18772436 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 293683 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 19150103 | ||
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 4.17e-10 | 3 | 27 | 3 | 31518043 | |
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 4.17e-10 | 3 | 27 | 3 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 4.17e-10 | 3 | 27 | 3 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 4.17e-10 | 3 | 27 | 3 | 25505062 | |
| Pubmed | 4.17e-10 | 3 | 27 | 3 | 31595054 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 4.17e-10 | 3 | 27 | 3 | 18786991 | |
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 4.17e-10 | 3 | 27 | 3 | 12466850 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 1.67e-09 | 4 | 27 | 3 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 1.67e-09 | 4 | 27 | 3 | 20363737 | |
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 1.67e-09 | 4 | 27 | 3 | 18572219 | |
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 1.67e-09 | 4 | 27 | 3 | 18983852 | |
| Pubmed | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | 1.67e-09 | 4 | 27 | 3 | 38049664 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 1.67e-09 | 4 | 27 | 3 | 29343743 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 1.67e-09 | 4 | 27 | 3 | 31400166 | |
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 1.67e-09 | 4 | 27 | 3 | 15674295 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 21873525 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 23725696 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 16378963 | ||
| Pubmed | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | 1.67e-09 | 4 | 27 | 3 | 26846717 | |
| Pubmed | Vaccinia virus replication is not affected by APOBEC3 family members. | 1.67e-09 | 4 | 27 | 3 | 17052331 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 21985787 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 19088851 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 1.67e-09 | 4 | 27 | 3 | 25355878 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 28415995 | ||
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 1.67e-09 | 4 | 27 | 3 | 26253512 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 9223268 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 19535450 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 25501566 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 20538015 | ||
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 1.67e-09 | 4 | 27 | 3 | 17020885 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 20375169 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 21147467 | ||
| Pubmed | Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s. | 1.67e-09 | 4 | 27 | 3 | 32893454 | |
| Pubmed | Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. | 1.67e-09 | 4 | 27 | 3 | 25303118 | |
| Pubmed | APOBEC3 inhibits mouse mammary tumour virus replication in vivo. | 1.67e-09 | 4 | 27 | 3 | 17259974 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 23555255 | ||
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 36480186 | ||
| Pubmed | Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. | 1.67e-09 | 4 | 27 | 3 | 15269786 | |
| Pubmed | 1.67e-09 | 4 | 27 | 3 | 16055735 | ||
| Pubmed | Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif. | 4.17e-09 | 5 | 27 | 3 | 20012521 | |
| Pubmed | APOBEC3 inhibits DEAD-END function to regulate microRNA activity. | 4.17e-09 | 5 | 27 | 3 | 23890083 | |
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 25461536 | ||
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 21659520 | ||
| Pubmed | IFN-α and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways. | 4.17e-09 | 5 | 27 | 3 | 22972924 | |
| Pubmed | AID and APOBECs span the gap between innate and adaptive immunity. | 4.17e-09 | 5 | 27 | 3 | 25352838 | |
| Interaction | APOBEC3D interactions | 1.41e-06 | 148 | 27 | 5 | int:APOBEC3D | |
| Interaction | PRRG3 interactions | 1.72e-05 | 5 | 27 | 2 | int:PRRG3 | |
| Interaction | PABPC5 interactions | 3.66e-05 | 142 | 27 | 4 | int:PABPC5 | |
| Interaction | CYYR1 interactions | 4.82e-05 | 8 | 27 | 2 | int:CYYR1 | |
| Interaction | NDST4 interactions | 4.82e-05 | 8 | 27 | 2 | int:NDST4 | |
| Interaction | CGAS interactions | 6.76e-05 | 329 | 27 | 5 | int:CGAS | |
| Interaction | MS4A10 interactions | 7.73e-05 | 10 | 27 | 2 | int:MS4A10 | |
| Interaction | PRRG2 interactions | 7.73e-05 | 10 | 27 | 2 | int:PRRG2 | |
| Interaction | TMEM252 interactions | 9.44e-05 | 11 | 27 | 2 | int:TMEM252 | |
| Interaction | ILDR1 interactions | 9.44e-05 | 11 | 27 | 2 | int:ILDR1 | |
| Interaction | SCN10A interactions | 9.44e-05 | 11 | 27 | 2 | int:SCN10A | |
| Interaction | LAPTM5 interactions | 9.70e-05 | 67 | 27 | 3 | int:LAPTM5 | |
| Interaction | ELAVL2 interactions | 1.09e-04 | 188 | 27 | 4 | int:ELAVL2 | |
| Interaction | LITAF interactions | 1.47e-04 | 77 | 27 | 3 | int:LITAF | |
| Interaction | MOB3A interactions | 1.56e-04 | 14 | 27 | 2 | int:MOB3A | |
| Interaction | PRRG1 interactions | 1.80e-04 | 15 | 27 | 2 | int:PRRG1 | |
| Interaction | PRR16 interactions | 2.05e-04 | 16 | 27 | 2 | int:PRR16 | |
| Interaction | SCN3A interactions | 2.05e-04 | 16 | 27 | 2 | int:SCN3A | |
| Interaction | SUSD6 interactions | 2.05e-04 | 16 | 27 | 2 | int:SUSD6 | |
| Interaction | ABT1 interactions | 2.19e-04 | 423 | 27 | 5 | int:ABT1 | |
| Interaction | ZC3H3 interactions | 2.21e-04 | 226 | 27 | 4 | int:ZC3H3 | |
| Interaction | TMEM255A interactions | 2.32e-04 | 17 | 27 | 2 | int:TMEM255A | |
| Interaction | TMEM92 interactions | 2.32e-04 | 17 | 27 | 2 | int:TMEM92 | |
| Interaction | TAF1B interactions | 2.49e-04 | 92 | 27 | 3 | int:TAF1B | |
| Interaction | TMEM174 interactions | 2.61e-04 | 18 | 27 | 2 | int:TMEM174 | |
| Interaction | LARP4B interactions | 2.78e-04 | 240 | 27 | 4 | int:LARP4B | |
| Interaction | RASL11B interactions | 2.91e-04 | 19 | 27 | 2 | int:RASL11B | |
| Interaction | SCN2A interactions | 2.91e-04 | 19 | 27 | 2 | int:SCN2A | |
| Interaction | PRR3 interactions | 3.05e-04 | 246 | 27 | 4 | int:PRR3 | |
| Interaction | CLIC2 interactions | 3.24e-04 | 20 | 27 | 2 | int:CLIC2 | |
| Interaction | SCN8A interactions | 3.24e-04 | 20 | 27 | 2 | int:SCN8A | |
| Interaction | RBMS2 interactions | 3.29e-04 | 251 | 27 | 4 | int:RBMS2 | |
| Interaction | KCNQ1 interactions | 3.57e-04 | 21 | 27 | 2 | int:KCNQ1 | |
| Interaction | SCN9A interactions | 3.57e-04 | 21 | 27 | 2 | int:SCN9A | |
| Interaction | GSPT2 interactions | 3.88e-04 | 107 | 27 | 3 | int:GSPT2 | |
| Interaction | SLC22A8 interactions | 3.93e-04 | 22 | 27 | 2 | int:SLC22A8 | |
| Interaction | SCNN1G interactions | 3.93e-04 | 22 | 27 | 2 | int:SCNN1G | |
| Interaction | KCNAB1 interactions | 5.09e-04 | 25 | 27 | 2 | int:KCNAB1 | |
| Interaction | SLC22A6 interactions | 6.39e-04 | 28 | 27 | 2 | int:SLC22A6 | |
| Interaction | SCNN1B interactions | 6.39e-04 | 28 | 27 | 2 | int:SCNN1B | |
| Interaction | FBXL15 interactions | 6.86e-04 | 29 | 27 | 2 | int:FBXL15 | |
| Interaction | SCN1A interactions | 6.86e-04 | 29 | 27 | 2 | int:SCN1A | |
| Interaction | PYM1 interactions | 7.32e-04 | 133 | 27 | 3 | int:PYM1 | |
| Interaction | RNFT1 interactions | 8.36e-04 | 32 | 27 | 2 | int:RNFT1 | |
| Interaction | NDST1 interactions | 9.44e-04 | 34 | 27 | 2 | int:NDST1 | |
| Interaction | NUP42 interactions | 1.02e-03 | 149 | 27 | 3 | int:NUP42 | |
| Interaction | RNF7 interactions | 1.04e-03 | 150 | 27 | 3 | int:RNF7 | |
| Interaction | PIP4P2 interactions | 1.12e-03 | 37 | 27 | 2 | int:PIP4P2 | |
| Interaction | N4BP1 interactions | 1.18e-03 | 38 | 27 | 2 | int:N4BP1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.32e-06 | 330 | 27 | 5 | chr22q13 | |
| Cytoband | 22q13.1 | 1.73e-05 | 85 | 27 | 3 | 22q13.1 | |
| Cytoband | 6q23.2 | 9.91e-05 | 25 | 27 | 2 | 6q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q22 | 1.24e-03 | 88 | 27 | 2 | chr17q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q23 | 2.24e-03 | 119 | 27 | 2 | chr6q23 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 8.08e-10 | 12 | 22 | 4 | 406 | |
| GeneFamily | Trace amine receptors | 5.06e-05 | 9 | 22 | 2 | 188 | |
| GeneFamily | Abhydrolase domain containing | 3.22e-04 | 22 | 22 | 2 | 4 | |
| GeneFamily | Sulfotransferases, membrane bound | 9.17e-04 | 37 | 22 | 2 | 763 | |
| GeneFamily | T-cell receptor alpha locus at 14q11.2 | 8.81e-03 | 117 | 22 | 2 | 371 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 9.56e-06 | 142 | 25 | 4 | MM3757 | |
| Coexpression | TABULA_MURIS_SENIS_THYMUS_DN4_THYMOCYTE_AGEING | 7.22e-05 | 238 | 25 | 4 | MM3845 | |
| Coexpression | MARTIN_VIRAL_GPCR_SIGNALING_UP | 7.44e-05 | 86 | 25 | 3 | M1327 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-06 | 191 | 27 | 4 | 95ae42d145adb478d886a2259baacc713cd6587b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.33e-06 | 193 | 27 | 4 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.33e-06 | 193 | 27 | 4 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.33e-06 | 193 | 27 | 4 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 6.14e-06 | 200 | 27 | 4 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 156 | 27 | 3 | 0de2fc695bd5f8d4633c514f71ea941c88137bac | |
| ToppCell | IIH-CD8-memory_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.13e-04 | 156 | 27 | 3 | e312fc4317d966fb2b570d1a4a3aa865f781ea93 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 156 | 27 | 3 | 4f92ca30755430db44402afc603d1ecd8bfc3617 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 159 | 27 | 3 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 159 | 27 | 3 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 165 | 27 | 3 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 165 | 27 | 3 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.43e-04 | 169 | 27 | 3 | dc388f660f69e37e517bf3243daf071ab138ee6e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 170 | 27 | 3 | 330b5fc8fde307eda9dcc7bc9053ea8a7e1f0f6d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 170 | 27 | 3 | 0c9d38e89b048166b879e6b4bdf7c5dfe8ab57c4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 171 | 27 | 3 | d5960b40ad5b87aaa00c93a6b31cdf41cc4f1375 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 171 | 27 | 3 | fd59ac4a39748840b2ee1c930ea475433ff61485 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 171 | 27 | 3 | d382430e5cdd0f2aac4fc093d8fe8d66efb4629b | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 171 | 27 | 3 | 4347e6f62c04ea43299893ad4b79719049009a56 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 179 | 27 | 3 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-04 | 180 | 27 | 3 | af7c4b9f1a0ddd894085cf93c29a6d253a7d077c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-04 | 180 | 27 | 3 | e35e9159f5cd9ec905b3b6e27d938158aeb9c51c | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.72e-04 | 180 | 27 | 3 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 180 | 27 | 3 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.74e-04 | 181 | 27 | 3 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-04 | 183 | 27 | 3 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 184 | 27 | 3 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.86e-04 | 185 | 27 | 3 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 187 | 27 | 3 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.95e-04 | 188 | 27 | 3 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.04e-04 | 191 | 27 | 3 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-CTL|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.08e-04 | 192 | 27 | 3 | e7e5ba94ee8fd3c04bb4c358c86d0227c563e9dc | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 1043b28503bfaa0d5a82ec358bc86cbde73ea8f2 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 0266a4fdf436d83ec1d9392abba8c6ec5166970a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-04 | 193 | 27 | 3 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 194 | 27 | 3 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.14e-04 | 194 | 27 | 3 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.17e-04 | 195 | 27 | 3 | c6e31038be2463f1601d52c82efa4e9facb8228f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 196 | 27 | 3 | 48b4a9cea97a55190217deaf51bf867608c5a9a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 196 | 27 | 3 | 473980c827443464d08a0be28c53e3536369b12a | |
| ToppCell | BL-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.20e-04 | 196 | 27 | 3 | cfbeaabbeeb197f0cf8240a752d1f2995d59d7b7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 196 | 27 | 3 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 197 | 27 | 3 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-04 | 198 | 27 | 3 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| Drug | C0761 | 6.52e-08 | 8 | 25 | 3 | CID006321196 | |
| Drug | N-cyclopropylammelide | 6.52e-08 | 8 | 25 | 3 | CID000592814 | |
| Disease | Liddle syndrome (implicated_via_orthology) | 4.13e-06 | 4 | 25 | 2 | DOID:0050477 (implicated_via_orthology) | |
| Disease | azoospermia (implicated_via_orthology) | 2.39e-04 | 27 | 25 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 1.84e-03 | 75 | 25 | 2 | DOID:1059 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.32e-03 | 152 | 25 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | autism spectrum disorder | 7.69e-03 | 156 | 25 | 2 | EFO_0003756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFFPMRYLPLWCYKN | 231 | Q7L211 | |
| EGQPFMPWYKFDDNY | 176 | Q96AK3 | |
| QQFMPWYKFDENYAF | 166 | Q9UH17 | |
| PFRMFYYAKDEWPFG | 76 | Q14330 | |
| AMYPGTFYFQFKNLW | 11 | Q9NRW3 | |
| WFFLISKEMFNPYYG | 1011 | P46934 | |
| YYYFFQIPWFPEFMF | 216 | Q8IUS5 | |
| YHKGIDWYMEFFPIP | 651 | P52848 | |
| YHKGIDWYMDFFPTP | 641 | Q9H3R1 | |
| FDFQWPQPDKPMFFY | 746 | Q92900 | |
| YSEGQPFMPWYKFDD | 161 | Q8IUX4 | |
| PFMPWYKFDDNYAFL | 166 | Q8IUX4 | |
| YIYTWPFTPFLMDKA | 256 | Q15615 | |
| PEAFYMIRFHSFYPW | 211 | Q9UGB7 | |
| PPKVFAFDYCFWSMD | 51 | Q9H1H9 | |
| YSFGFGKAMPWFQFY | 206 | Q8IWB6 | |
| MNPLIYAFFYQWFGK | 306 | Q96RI9 | |
| YFMRYWILKFPAEFN | 76 | Q8IV61 | |
| FLSWFPFYYMLKCGF | 106 | Q00765 | |
| FYLFYNFEYWFLPMK | 321 | O75503 | |
| NFEYWFLPMKFPFIK | 326 | O75503 | |
| RFFKENWPQYSQMYP | 116 | P0CB48 | |
| DYYLFWYKQPPSRQM | 51 | P0DTU3 | |
| KYPLQLFPMWRFPFY | 191 | Q687X5 | |
| NSTFNPMVYAFFYPW | 296 | Q96RJ0 | |
| PMVYAFFYPWFRKAL | 301 | Q96RJ0 | |
| DYYLFWYKQPPSRQM | 51 | A0JD32 | |
| FYFFKSFQYPLPWSE | 166 | Q9H1V8 | |
| YNNKPFMGRFYEWEP | 321 | Q6ZMP0 | |
| EWFFLLSKEMFNPYY | 666 | Q96PU5 |